QleanUP at a glance

The General Court of the CJEU has dismissed a legal challenge from the pharmaceutical industry (EFPIA) against the recast Urban Wastewater Treatment Directive (UWWTD). This ruling confirms the validity of the Extended Producer Responsibility (EPR) scheme.

The Decision

Pharmaceutical and cosmetic companies are now legally required to contribute to the costs of “quaternary treatment”—advanced wastewater filtration designed to remove micropollutants. The industry had argued that the costs were disproportionate and discriminatory, but the Court rejected these claims in their entirety.

Why It Matters

The ruling reinforces the “polluter-pays” principle. It ensures that the industries responsible for micropollution contribute to infrastructure costs, protecting aquatic ecosystems while shielding water users from significant tariff increases.

Next Steps

July 2027: Deadline for EU Member States to transpose the Directive into national law.
December 2028: The EPR scheme becomes fully operational across Europe.

This legal confirmation provides the certainty needed for water managers to move forward with advanced treatment technologies, a core focus of the QleanUP project.